Skip to main content
. 2019 Jun 27;47(8):3709–3718. doi: 10.1177/0300060519850724

Figure 2.

Figure 2.

Correlation between long noncoding RNA promoter and pre-rRNA antisense (PAPAS) expression in tumour and tumour-adjacent healthy tissue, and plasma PAPAS levels, in patients with triple-negative breast cancer: Pearson’s correlation coefficient analysis showed that PAPAS expression in (a) tumour tissue, but not in (b) tumour-adjacent healthy tissue, was significantly and positively correlated with plasma PAPAS levels.